148 results found.

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesop Clinical Trial using radiation therapy; paclitaxel; carboplatin; trastuzumab; therapeutic conventional surgery; laboratory biomarker analysis; quality-of-life assessment

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase III Trial Evaluating The Addition Of Trastuzumab To Trimodality Treatment Of Her2-Overexpressing Esophageal Adenocarcinoma.
radiation therapy; paclitaxel; carboplatin; trastuzumab; therapeutic conventional surgery; laboratory biomarker analysis; quality-of-life assessment

Adenocarcinoma, Pancreas, or Neuroendocrine Tumor, Pancreas Clinical Trial using iopromide; CT

Seoul National University Hospital - Recruiting 18 years or older.
- Evaluation of Diagnostic Efficacy of Perfusion CT Using Wide Detector for Staging and Response Prediction After Chemotherapy in Pancreatic Cancer.
iopromide; CT

Pancreatic Cancer Clinical Trial using Gemcitabine; Radiation therapy; pancreaticoduodenectomy

University of Arkansas - Recruiting 18 years or older.
- A Phase II Study to Assess the Efficacy and Safety of Preoperative Chemotherapy With Radiation Therapy for Patients With Borderline Unresectable Adenocarcinoma of the Pancreas.
Gemcitabine; Radiation therapy; pancreaticoduodenectomy

Carcinoma, Non-Small-Cell Lung Clinical Trial using afatinib; loperamide

Boehringer Ingelheim - Recruiting 18 years or older.
- A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM).
afatinib; loperamide

Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adeno Clinical Trial using veliparib; pegylated liposomal doxorubicin hydrochloride; carboplatin; bevacizumab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I Trial of Pegylated Liposomal Doxorubicin (PLD), Carboplatin, and NCI Supplied Veliparib (ABT-888), and NCI Supplied Bevacizumab in Recurrent Platinum Sensitive Ovarian, Primary Peritoneal and Fallopian Tube Cancer.
veliparib; pegylated liposomal doxorubicin hydrochloride; carboplatin; bevacizumab; laboratory biomarker analysis

Adenocarcinoma of Head of Pancreas, Cholangio Carcinoma, Duodenal Clinical Trial using Open surgery; Laparoscopic surgery

GEM Hospital & Research Center - Recruiting 30 years to 70 years.
- A Prospective Randomized Parallel Group Trial : Laparoscopic Versus Open Pancreatoduodenectomy in Terms of Pathological Radicality & Severity Short Term of Complications According to Expanded Accordion Severity Grading System.
Open surgery; Laparoscopic surgery

Gastric Cancer Clinical Trial using GDC-0068; Placebo; mFOLFOX6

Genentech - Recruiting 18 years or older.
- A Randomized, Phase II, Placebo Controlled Study of GDC-0068, an Inhibitor to Akt, in Combination With Fluoropyrimidine Plus Oxaliplatin in Patients With Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma.
GDC-0068; Placebo; mFOLFOX6

Adenocarcinoma of the Prostate Clinical Trial using EPISPOT detection of the number of circulating cells; CellSearch detection of the number of circulating, functional, prostate cells

Centre Hospitalier Universitaire de NÄ«mes - Recruiting 18 years or older.
- The Pre-treatment Detection of Circulating, Functional, Prostate Cells Among Adenocarcinoma Patients: an Evaluation of the EPISPOT Technique.
EPISPOT detection of the number of circulating cells; CellSearch detection of the number of circulating, functional, prostate cells

Pancreatic Cancer Clinical Trial using Gemcitabine

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas.
Gemcitabine

Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Clinical Trial using oxaliplatin; irinotecan hydrochloride; leucovorin calcium; fluorouracil; laboratory biomarker analysis

University of Chicago - Recruiting 18 years or older.
- A Genotype-guided Dosing Study of mFOLFIRINOX in Previously Untreated Patients With Advanced Gastrointestinal Malignancies.
oxaliplatin; irinotecan hydrochloride; leucovorin calcium; fluorouracil; laboratory biomarker analysis

Pancreatic Cancer Clinical Trial using Gemcitabine

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Tissue Pharmacokinetics of Intraoperative Gemcitabine in Adenocarcinoma of the Pancreas After Preoperative Chemoradiation Therapy.
Gemcitabine

Pancreatic Diseases, Pancreatic Neoplasms, or Pancreatitis Clinical Trial using No interventions, this is an observational study

Aalborg Universityhospital - Recruiting 18 years or older.
- Cell-free DNA Promoter Hypermethylation in Plasma From Patients With Pancreatic Adenocarcinoma, Compared to Patients With Pancreatitis and Pancreatitis and Patients Screened for, But Not Having Pancreatic Adenocarcinoma.'.
No interventions, this is an observational study

Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, C Clinical Trial using live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001; laboratory biomarker analysis

Gynecologic Oncology Group - Recruiting 18 years or older.
- A Phase II Evaluation of ADXS11-001 (NSC 752718, BB-IND#13,712) in the Treatment of Persistent or Recurrent Squamous or Non-Squamous Cell Carcinoma of the Cervix.
live-attenuated Listeria monocytogenes cancer vaccine ADXS11-001; laboratory biomarker analysis

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystaden Clinical Trial using laboratory biomarker analysis

Gynecologic Oncology Group - Recruiting 18 years or older.
- A Prospective, Longitudinal Study of YKL-40 in Patients With FIGO Stage III or IV Invasive Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Undergoing Primary Chemotherapy.
laboratory biomarker analysis

Pancreatic Neoplasms Clinical Trial using Oxaliplatin; Irinotecan; Leucovorin; Fluorouracil; laboratory biomarker analysis; flow cytometry; immunohistochemistry staining method; pharmacological study; PF-04136309

Washington University School of Medicine - Recruiting 18 years or older.
- Phase IB Study of FOLFIRINOX Plus PF-04136309 in Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma.
Oxaliplatin; Irinotecan; Leucovorin; Fluorouracil; laboratory biomarker analysis; flow cytometry; immunohistochemistry staining method; pharmacological study; PF-04136309

Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian End Clinical Trial using behavioral dietary intervention; exercise intervention; counseling intervention; educational intervention; compliance monitoring; questionnaire administration; quality-of-life assessment; laboratory biomarker analysis

Gynecologic Oncology Group - Recruiting 18 years or older.
- Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?.
behavioral dietary intervention; exercise intervention; counseling intervention; educational intervention; compliance monitoring; questionnaire administration; quality-of-life assessment; laboratory biomarker analysis

Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian End Clinical Trial using elesclomol sodium; paclitaxel

Gynecologic Oncology Group - Recruiting 18 years or older.
- A PHASE II EVALUATION OF ELESCLOMOL SODIUM AND WEEKLY PACLITAXEL IN THE TREATMENT OF RECURRENT OR PERSISTENT PLATINUM-RESISTANT OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER.
elesclomol sodium; paclitaxel

Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, C Clinical Trial using laboratory biomarker analysis; lymphadenectomy

Gynecologic Oncology Group - Recruiting 18 years or older.
- Glycoprotein and Glycan Profiling in Patients With Locally Advanced Cervical Cancer (Stage IB2, IIA > 4 CM, IIB to IVA) Undergoing Pelvic and Para-Aortic (Abdominal) Lymphadenectomy.
laboratory biomarker analysis; lymphadenectomy

Neoplasms, Pancreas Clinical Trial using cancer stem cell vaccine

Fuda Cancer Hospital, Guangzhou - Recruiting 18 years to 75 years.
- Study of Cancer Stem Cell Vaccine That as a Specific Antigen in Metastatic Adenocarcinoma of the Pancreas.
cancer stem cell vaccine

Ovarian Cancer Clinical Trial using bevacizumab [Avastin]; Carboplatin; paclitaxel

Hoffmann-La Roche - Recruiting 18 years or older.
- A Randomized, Open-label, Phase II Study Assessing the Efficacy and the Safety of Bevacizumab in Neoadjuvant Therapy in Patients With FIGO Stage IIIC/IV Ovarian, Tubal or Peritoneal Adenocarcinoma, Initially Unresectable..
bevacizumab [Avastin]; Carboplatin; paclitaxel

Gastric Cancer Clinical Trial using trastuzumab emtansine; taxane

Hoffmann-La Roche - Recruiting 18 years or older.
- A Randomized, Multicenter, Adaptive Phase II/III Study To Evaluate The Efficacy And Safety Of Trastuzumab Emtansine (T-DM1) Versus Taxane (Docetaxel Or Paclitaxel) In Patients With Previously Treated Locally Advanced Or Metastatic Her2-Positive Gastric Cancer, Including Adenocarcinoma Of The Gastroesophageal Junction.
trastuzumab emtansine; taxane

Metastatic Pancreatic Adenocarcinoma Clinical Trial using Ipilimumab; Vaccine; FOLFIRINOX

Sidney Kimmel Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase 2, Multicenter Study of FOLFIRINOX Followed by Ipilimumab in Combination With Allogeneic GM-CSF Transfected Pancreatic Tumor Vaccine (GVAX) in the Treatment of Metastatic Pancreatic Cancer.
Ipilimumab; Vaccine; FOLFIRINOX

EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Clinical Trial

AstraZeneca - Recruiting 18 years or older.
- A Diagnostic Study of European and Japanese Advanced NSCLC Patients to Evaluate Suitable Sample Types for EGFR Testing,.

Metastatic Pancreatic Adenocarcinoma Clinical Trial using PEGPH20; Oxaliplatin; Leucovorin; Irinotecan; 5-fluorouracil

Southwest Oncology Group - Recruiting 18 years or older.
- S1313, A Phase IB/II Randomized Study of Modified FOLFIRINOX + Pegylated Recombinant Human Hyaluronidase (PEGPH20) Versus Modified FOLFIRINOX Alone in Patients With Good Performance Status Metastatic Pancreatic Adenocarcinoma.
PEGPH20; Oxaliplatin; Leucovorin; Irinotecan; 5-fluorouracil

Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, C Clinical Trial using triapine; cisplatin; external beam radiation therapy; brachytherapy; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Randomized Phase II Study of Intravenous 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone (3-AP, Triapiner NSC #663249) Cisplatin-Radiochemotherapy Versus Intravenous Cisplatin-Radiochemotherapy in Women Diagnosed With Stage IB-IVA Cervical Cancer and Stage II-IVA Vaginal Cancer.
triapine; cisplatin; external beam radiation therapy; brachytherapy; laboratory biomarker analysis

Colorectal Cancer, Liver Metastasis, or Colorectal Adenocarcinoma Clinical Trial using Sulindac; Placebo

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Phase 2 Prospective Randomized Double Blind Trial Comparing Metastasectomy Plus Sulindac Versus Metastasectomy Alone in Patients With Stage IV Colorectal Cancer.
Sulindac; Placebo

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcin Clinical Trial using vismodegib; sirolimus; positron emission tomography; computed tomography; pharmacological study; laboratory biomarker analysis; fludeoxyglucose F 18

Mayo Clinic - Recruiting 18 years or older.
- Phase I Trial of The Combination of Vismodegib and Sirolimus.
vismodegib; sirolimus; positron emission tomography; computed tomography; pharmacological study; laboratory biomarker analysis; fludeoxyglucose F 18

Prostate Cancer Clinical Trial using LHRH; Docetaxel; Conformal RT

Proton Collaborative Group - Recruiting 18 years to 75 years.
- Phase 2/3 Study of Dose-escalated External Beam Radiation Therapy With or Without Chemotherapy for High Risk Adenocarcinoma of the Prostate.
LHRH; Docetaxel; Conformal RT

Prostate Cancer Clinical Trial using Proton Radiation Hypofractionation; Proton Radiation Standard Fractionation

Proton Collaborative Group - Recruiting 18 years or older.
- A Phase III Prospective Randomized Trial of Standard-fractionation vs. Hypo-fractionation With Proton Radiation Therapy for Low Risk Adenocarcinoma of the Prostate.
Proton Radiation Hypofractionation; Proton Radiation Standard Fractionation

Prostate Cancer Clinical Trial using Proton Radiation; Androgen Suppression Therapy

Proton Collaborative Group - Recruiting 18 years or older.
- Phase III Study of Mildly Hypo-fractionated Image Guided Proton Beam Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Adenocarcinoma of the Prostate.
Proton Radiation; Androgen Suppression Therapy

Pancreatic Cancer Clinical Trial using Oxaliplatin; Irinotecan; 5-FU; Gemcitabine; Radiation Therapy

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Preoperative Systemic Chemotherapy (Modified FOLFIRINOX) Followed by Radiation Therapy for Patients With High Risk Resectable and Borderline Resectable Adenocarcinoma of the Pancreas.
Oxaliplatin; Irinotecan; 5-FU; Gemcitabine; Radiation Therapy

Gastric Adenocarcinoma Clinical Trial using Capecitabine; Oxaliplatin

Shanghai Zhongshan Hospital - Recruiting 18 years to 75 years.
- A Multicenter, Single Arm, Open-label Trial of Oxaliplatin Plus Capecitabine (XELOX) in the Perioperative Treatment of Locally Advanced Gastric Adenocarcinoma.
Capecitabine; Oxaliplatin

Gastric Cancer Clinical Trial using trastuzumab [Herceptin]; Oxaliplatin; capecitabine; Radiation

Hoffmann-La Roche - Recruiting 18 years to 75 years.
- Safety and Tolerability of Oxaliplatin-Capecitabine-Trastuzumab Combination and Chemoradiotherapy in Adjuvant Setting in Operated HER2+ Patients With Gastric or Gastroesophageal Junction Adenocarcinoma: A Phase II Study (TOXAG Study).
trastuzumab [Herceptin]; Oxaliplatin; capecitabine; Radiation

Malignant Solid Tumour, or Gastroesophageal Cancer Clinical Trial using Tivantinib; FOLFOX

SCRI Development Innovations, LLC - Recruiting 18 years or older.
- A Phase I/II Trial of the c-Met Inhibitor, Tivantinib, in Combination With FOLFOX for the Treatment of Patients With Advanced Solid Tumors (Phase I) and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal (GE) Junction, or Stomach (Phase II).
Tivantinib; FOLFOX

Endometrial Adenocarcinoma, Endometrial Papillary Serous Carcinom Clinical Trial using trametinib; Akt inhibitor GSK2141795; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Randomized Phase II Study With Safety Lead-in to Assess the Antitumor Efficacy of the Mek Inhibitor Trametinib Alone or in Combination With GSK2141795, an Akt Inhibitor, in Patients With Recurrent or Persistent Endometrial Cancer.
trametinib; Akt inhibitor GSK2141795; laboratory biomarker analysis

2nd-line, 3rd-line and Greater Metastatic Pancreatic Cancer Clinical Trial using GVAX Pancreas Vaccine; CRS-207; gemcitabine, capecitabine, 5-FU, irinotecan or erlotinib; cyclophosphamide

Aduro BioTech, Inc. - Recruiting 18 years or older.
- A Phase 2B, Randomized, Controlled, Multicenter, Open-Label Study of the Efficacy and Immune Response of GVAX Pancreas Vaccine (With Cyclophosphamide) and CRS 207 Compared to Chemotherapy or to CRS-207 Alone in Adults With Previously-Treated Metastatic Pancreatic Adenocarcinoma.
GVAX Pancreas Vaccine; CRS-207; gemcitabine, capecitabine, 5-FU, irinotecan or erlotinib; cyclophosphamide

Stomach Neoplasms Clinical Trial using AMG 337

Amgen - Recruiting 18 years or older.
- A Multicenter, Phase 2, Single Arm, Two Cohort Study Evaluating the Efficacy, Safety, and Pharmacokinetics of AMG337 in Subjects With MET Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma or Other MET Amplified Solid Tumors.
AMG 337

Gastric Cancer Clinical Trial using Rilotumumab; Placebo

Amgen - Recruiting 18 years or older.
- A Phase 3, Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Rilotumumab (AMG102) With Epirubicin, Cisplatin, and Capecitabine (ECX) as First-line Therapy in Advanced MET-Positive Gastric or Gastroesophageal Junction Adenocarcinoma.
Rilotumumab; Placebo

Colorectal Cancers Clinical Trial using RENCA macrobeads

The Rogosin Institute - Recruiting 18 years or older.
- A Phase IIb, Nonrandomized, Open-Label Trial With Mouse Renal Adenocarcinoma (RENCA) Cell Containing Agarose-Agarose Macrobeads Compared With Best Supportive Care in Patients With Treatment-Resistant, Metastatic Colorectal Carcinoma.
RENCA macrobeads

Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, C Clinical Trial using quality-of-life assessment; questionnaire administration; cone biopsy; loop electrosurgical excision procedure

Gynecologic Oncology Group - Recruiting 18 years or older.
- Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (=/<2CM) Cervical Cancer.
quality-of-life assessment; questionnaire administration; cone biopsy; loop electrosurgical excision procedure

Adenocarcinoma, or Pancreatic Neoplasms Clinical Trial using X-82; Everolimus

Washington University School of Medicine - Recruiting 18 years or older.
- A Phase I/II Study of X-82, an Oral Anti-VEGFR Tyrosine Kinase Inhibitor, With Everolimus for Patients With Pancreatic Neuroendocrine Tumors.
X-82; Everolimus

Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Ca Clinical Trial using ipilimumab; gemcitabine hydrochloride; laboratory biomarker analysis

Northwestern University - Recruiting 18 years or older.
- Ipilimumab and Gemcitabine for Advanced Pancreas Cancer: A Phase Ib Study.
ipilimumab; gemcitabine hydrochloride; laboratory biomarker analysis

Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer, Lar Clinical Trial using PI3K inhibitor BKM120; pemetrexed disodium; carboplatin; laboratory biomarker analysis; pharmacological study; quality-of-life assessment

City of Hope Medical Center - Recruiting 18 years or older.
- Phase I Trial of BKM120 in Combination With Carboplatin and Pemetrexed in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC).
PI3K inhibitor BKM120; pemetrexed disodium; carboplatin; laboratory biomarker analysis; pharmacological study; quality-of-life assessment

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcin Clinical Trial using gemcitabine hydrochloride; dasatinib; erlotinib hydrochloride

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase 1 Study of Gemcitabine, Dasatinib and Erlotinib in Patients With Advanced Pancreatic Carcinoma.
gemcitabine hydrochloride; dasatinib; erlotinib hydrochloride

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystaden Clinical Trial using paclitaxel; docetaxel; carboplatin; bevacizumab; gemcitabine hydrochloride; laboratory biomarker analysis; quality-of-life assessment

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865, IND #113912) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865, IND #113912).
paclitaxel; docetaxel; carboplatin; bevacizumab; gemcitabine hydrochloride; laboratory biomarker analysis; quality-of-life assessment

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistan Clinical Trial using sipuleucel-T; external beam radiation therapy; laboratory biomarker analysis

City of Hope Medical Center - Recruiting 18 years or older.
- Randomized Phase II Trial of Sipuleucel T Immunotherapy Preceded by Sensitizing Radiation Therapy and Sipuleucel-T Alone in Patients With Castrate Resistant Metastatic Prostate Cancer.
sipuleucel-T; external beam radiation therapy; laboratory biomarker analysis

Gastrointestinal Cancer Clinical Trial using Panitumumab

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Phase II Study of Panitumumab in KRAS Wild-type Locally Advanced or Metastatic Adenocarcinoma of the Small Bowel or Ampulla of Vater.
Panitumumab

Lung Cancer Clinical Trial using Sunitinib

Dana-Farber Cancer Institute - Recruiting 18 years or older.
- A Phase II Trial of Sunitinib in Never-smokers With Lung Adenocarcinoma: Identification of Oncogenic Alterations Underlying Sunitinib Sensitivity.
Sunitinib

Carcinoma Clinical Trial

Onkovis GmbH - Recruiting N/A or older.
- Open, Multicenter Observational Study of Docetaxel Utilized in Mono- or Combination Therapy for Treatment of Breast Cancer, NSCLC, Prostate Carcinoma, Adenocarcinoma of Stomach and Advanced Squamous Cell Carcinoma of Head/Neck Region..

Melanoma, Breast Neoplasms, Lobular Carcinoma, Triple-negative Br Clinical Trial using LGK974

Novartis - Recruiting 18 years or older.
- A Phase I, Open-label, Dose Escalation Study of Oral LGK974 in Patients With Malignancies Dependent on Wnt Ligands.
LGK974

Pancreas Cancer Clinical Trial using Whipple at the Splenic Artery (WATSA)

Washington University School of Medicine - Recruiting 18 years to 85 years.
- Whipple at the Splenic Artery - A Procedure for Ductal Adenocarcinoma of the Pancreas With Extensive Involvement of the Porto-Mesenteric Axis: A Registry Study.
Whipple at the Splenic Artery (WATSA)

Left-sided Pancreatic Cancer, or Ductal Adenocarcinoma Clinical Trial using Radical Antegrade Modular Pancreatectomy with Splenectomy; Radical Antegrade Modular Pancreatectomy without splenectomy

Yonsei University - Recruiting 20 years to 80 years.
- .
Radical Antegrade Modular Pancreatectomy with Splenectomy; Radical Antegrade Modular Pancreatectomy without splenectomy

KRAS Mutated Colorectal Adenocarcinoma, Metastatic Pancreatic Ade Clinical Trial using MEK162 + AMG 479

Novartis - Recruiting 18 years or older.
- A Phase Ib/II Open-label, Multi-center Study of the Combination of MEK162 Plus AMG 479 (Ganitumab) in Adult Patients With Selected Advanced Solid Tumors.
MEK162 + AMG 479

Colorectal Cancer Clinical Trial using GS-6624; FOLFIRI; Placebo to match GS-6624

Gilead Sciences - Recruiting 18 years or older.
- A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-6624 Combined With FOLFIRI as Second Line Treatment for Metastatic KRAS Mutant Colorectal Adenocarcinoma That Has Progressed Following a First Line Oxaliplatin- and Fluoropyrimidine-Containing Regimen..
GS-6624; FOLFIRI; Placebo to match GS-6624

Pancreatic Cancer Clinical Trial using TH-302; Nab-paclitaxel; Gemcitabine

EMD Serono - Recruiting 18 years or older.
- An Open-Label, Phase I Dose Escalation Trial of TH-302 in Combination With Gemcitabine and Nab-Paclitaxel in Previously Untreated Subjects With Metastatic or Locally Advanced Unresectable Pancreatic Adenocarcinoma.
TH-302; Nab-paclitaxel; Gemcitabine

Carcinoma, Renal Cell, Non Clear Cell Renal Carcinoma, Papillary Clinical Trial using RAD001

Novartis - Recruiting 18 years or older.
- A Single Arm, Multicenter Phase II Trial of RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Cancer.
RAD001

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcin Clinical Trial using oxaliplatin; leucovorin calcium; irinotecan hydrochloride; fluorouracil; therapeutic conventional surgery; laboratory biomarker analysis

Yale University - Recruiting 18 years or older.
- Phase II Study of Peri-Operative Modified Folfirinox in Localized Pancreatic Cancer.
oxaliplatin; leucovorin calcium; irinotecan hydrochloride; fluorouracil; therapeutic conventional surgery; laboratory biomarker analysis

Locally Advanced (Unresectable) or Metastatic Adenocarcinoma of t Clinical Trial using Ipilimumab; Best Supportive care (BSC)

Bristol-Myers Squibb - Recruiting 18 years or older.
- A Randomized, Open-label, Two-arm Phase II Trial Comparing the Efficacy of Sequential Ipilimumab Versus Best Supportive Care Following First-line Chemotherapy in Subjects With Unresectable Locally Advanced/Metastatic Gastric or Gastro-esophageal Junction Cancer.
Ipilimumab; Best Supportive care (BSC)

Pancreatic Adenocarcinoma Clinical Trial

Centre Hospitalier Departemental Vendee - Recruiting 18 years or older.
- PAncreatic Adenocarcinoma in Hospital.

Lung Adenocarcinoma, or Brain Metastases Clinical Trial using erlotinib; pemetrexed; cisplatin

Guangzhou Medical University - Recruiting 18 years or older.
- Phase 2 Study of Erlotinib Plus Pemetrexed/Cisplatin Treating Lung Adenocarcinoma With Brain Metastases.
erlotinib; pemetrexed; cisplatin

Non-Small Cell Lung Cancer Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- AVAdeno: Non-interventional Study of Avastin 1st Line Therapy in Adenocarcinoma Patients of the Lung.

Non-Small Cell Lung Cancer Clinical Trial using erlotinib [Tarceva]

Hoffmann-La Roche - Recruiting 18 years or older.
- Open Label Study of Erlotinib (Tarcevar) as Single Agent First Line Treatment of Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With Activating Epidermal Growth Factor Receptor (EGFR) Mutations.
erlotinib [Tarceva]

Non-Small Cell Lung Cancer Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- Efficacy and Safety of erLotinib (Tarcevar ) Therapy in patiEnts With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) , Subtype adEnocarcinoma, Who Have Good performaNce sTatus (PS 0-1) - ELEMENT.

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesop Clinical Trial using oxaliplatin; leucovorin calcium; fluorouracil; therapeutic conventional surgery; radiation therapy; carboplatin; paclitaxel

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase II Trial of Modified FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Response Based Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Adenocarcinoma of the Esophagus, Gastro-esophageal Junction, and Gastric Cardia.
oxaliplatin; leucovorin calcium; fluorouracil; therapeutic conventional surgery; radiation therapy; carboplatin; paclitaxel

Barrett's Esophagus, or Early Esophageal Adenocarcinoma Clinical Trial using Biopsy

Mayo Clinic - Recruiting 18 years to 90 years.
- The Effect of Ablation Therapy on Barrett's Esophagus.
Biopsy

Barrett's Esophagus With Persistent Dysplasia or, or Early Esopha Clinical Trial

Mayo Clinic - Recruiting 18 years or older.
- CryoSpray Ablation for Barrett's Esophagus After Treatment Failure With Serial RadioFrequency Ablation.

Gastric Cancer Clinical Trial using Ramucirumab

Eli Lilly and Company - Recruiting 20 years or older.
- A Phase 2 Study of Ramucirumab in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First Line Platinum- or Fluoropyrimidine-Containing Combination Therapy in Japanese Patients.
Ramucirumab

Pancreatic Adenocarcinoma Clinical Trial using NovoTTF-100L; Gemcitabine

NovoCure Ltd. - Recruiting 18 years or older.
- An Open Label Pilot Study of NovoTTF-100L Concomitant With Gemcitabine for Front-line Therapy of Advanced Pancreatic Adenocarcinoma.
NovoTTF-100L; Gemcitabine

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcin Clinical Trial using 6,8-bis(benzylthio)octanoic acid; oxaliplatin; leucovorin calcium; irinotecan hydrochloride; fluorouracil; laboratory biomarker analysis

Comprehensive Cancer Center of Wake Forest University - Recruiting 18 years or older.
- A Phase I Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer and Good Performance Status.
6,8-bis(benzylthio)octanoic acid; oxaliplatin; leucovorin calcium; irinotecan hydrochloride; fluorouracil; laboratory biomarker analysis

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcin Clinical Trial using 6,8-bis(benzylthio)octanoic acid

Comprehensive Cancer Center of Wake Forest University - Recruiting 18 years or older.
- A Pilot Study: Open-Label Clinical Trial of CPI-613 in Patients With Metastatic Pancreatic Adenocarcinoma and Poor Performance Status.
6,8-bis(benzylthio)octanoic acid

Pancreatic Cancer, or Colorectal Cancer Clinical Trial using Cancer macrobead placement in abdominal cavity

The Rogosin Institute - Recruiting 18 years or older.
- An Open-Label Phase 2 Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Cell-Containing Agarose-Agarose Macrobeads in the Treatment of Patients With Treatment-Resistant, Metastatic Pancreatic or Colorectal Adenocarcinoma.
Cancer macrobead placement in abdominal cavity

Gastrointestinal Cancers Clinical Trial using Capecitabine; Oxaliplatin; Bevacizumab

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Phase II Study of Bevacizumab Combined With Capecitabine and Oxaliplatin (CAPOX) in Patients With Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater.
Capecitabine; Oxaliplatin; Bevacizumab

Cervical Adenocarcinoma, Cervical Squamous Cell Carcinoma, Human Clinical Trial using ipilimumab; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase 2 Study of Ipilimumab in Women With Metastatic or Recurrent HPV-Related Cervical Carcinoma of Either Squamous Cell or Adenocarcinoma Histologies.
ipilimumab; laboratory biomarker analysis

Prostate Cancer Clinical Trial using Cancer Macrobead placement in abdominal cavity

The Rogosin Institute - Recruiting 18 years or older.
- An Open-Label, Phase 2 Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Cell-Containing Agarose- Agarose Macrobeads in the Treatment of Patients With Castration-Resistant Prostate Cancer Resistant to Docetaxel.
Cancer Macrobead placement in abdominal cavity

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, or S Clinical Trial using wild-type reovirus; carboplatin; paclitaxel

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A 2-arm Randomized Phase II Study of Carboplatin, Paclitaxel Plus Reovirus Serotype-3 Dearing Strain (Reolysinr) vs. Carboplatin and Paclitaxel in the First Line Treatment of Patients With Recurrent or Metastatic Pancreatic Cancer.
wild-type reovirus; carboplatin; paclitaxel

Gastric Cancer Clinical Trial using RAD001

Chinese University of Hong Kong - Recruiting 18 years or older.
- Phase I/II Study of Paclitaxel / Carboplatin / RAD001 as First Line Therapy for Advanced Adenocarcinoma of the Stomach.
RAD001

Gastric Adenocarcinoma Clinical Trial using HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) with oxaliplatin; Curative gastrectomy

Hospices Civils de Lyon - Recruiting 18 years to 75 years.
- GASTRICHIP : D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma. A National Randomized and Multicentric Phase III Study..
HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) with oxaliplatin; Curative gastrectomy

Gastric Cancer Clinical Trial using Cabazitaxel

Krankenhaus Nordwest - Recruiting 18 years or older.
- Multicentre, Phase II Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Adenocarcinoma of the Oesophagogastric Junction and Stomach.
Cabazitaxel

Non-small Cell Lung Cancer(NSCLC) Clinical Trial using erlotinib; docetaxel

National Taiwan University Hospital - Recruiting 18 years or older.
- An Open-label, Randomized, Phase II Study of Erlotinib Monotherapy Versus Docetaxel and Cisplatin as Neoadjuvant Therapy in Patients of Stage IIIA Lung Adenocarcinoma With Epidermal Growth Factor Receptor Gene Mutation..
erlotinib; docetaxel

Gastroesophageal Junction Adenocarcinoma, or Gastric Cancer Clinical Trial using Docetaxel, Leucovorin, Fluorouracil, Cisplatin; Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen

Memorial Sloan-Kettering Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Patients With Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma.
Docetaxel, Leucovorin, Fluorouracil, Cisplatin; Docetaxel, Cisplatin, Fluorouracil, Neulasta, or Neupogen

Metastatic or Recurrent Gastric Adenocarcinoma, or Her-2 Positive Clinical Trial using Herceptin+XELOX

Asan Medical Center - Recruiting 20 years or older.
- A Phase II Study of Trastuzumab in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer.
Herceptin+XELOX

Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cance Clinical Trial using FOLFOX regimen; docetaxel; fluorouracil; irinotecan hydrochloride; leucovorin calcium; oxaliplatin

Southwest Oncology Group - Recruiting 18 years or older.
- A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer.
FOLFOX regimen; docetaxel; fluorouracil; irinotecan hydrochloride; leucovorin calcium; oxaliplatin

Esophageal Neoplasms, Adenocarcinoma of the Gastroesophageal Junc Clinical Trial using DKN-01; Paclitaxel

Dekkun Corporation - Recruiting 30 years or older.
- A Two Part, Phase 1, Multi-Center, Open-Label Study of DKN-01 in Combination With Weekly Paclitaxel in Patients With Relapsed or Refractory Esophageal Cancer or Gastro-Esophageal Junction Tumors.
DKN-01; Paclitaxel

Metastatic Pancreatic Cancer, or Pancreatic Cancer Clinical Trial using IMMU-107; placebo; Gemcitabine

Immunomedics, Inc. - Recruiting 18 years or older.
- An International, Multi-Center, Double-Blind, Randomized, Phase III Trial of 90Y-Clivatuzumab Tetraxetan Plus Low-Dose Gemcitabine Versus Placebo Plus Low-Dose Gemcitabine in Patients With Metastatic (Stage IV) Pancreatic Adenocarcinoma Who Received at Least Two Prior Treatments (PANCRIT-1).
IMMU-107; placebo; Gemcitabine

Rectal Cancer Clinical Trial using Sorafenib; 5-Fluorouracil (5-FU); Radiation

H. Lee Moffitt Cancer Center and Research Institute - Recruiting 18 years or older.
- Phase I Study of Pre-operative Continuous 5-FU, and Sorafenib With External Radiation Therapy in Locally Advanced Rectal Adenocarcinoma.
Sorafenib; 5-Fluorouracil (5-FU); Radiation

Prostate Adenocarcinoma Clinical Trial using Stereotactic Ablative Radiation

Sunnybrook Health Sciences Centre - Recruiting 18 years or older.
- Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer.
Stereotactic Ablative Radiation

Patients Must Have Previously Untreated Apparently Resectable Ade Clinical Trial using Paricalcitol

Abramson Cancer Center of the University of Pennsylvania - Recruiting 18 years or older.
- A Randomized Pilot/Pharmacodynamic/Genomic Study of Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer.
Paricalcitol

Adenocarcinoma of Prostate, or Progression of Prostate Cancer Clinical Trial using Cabazitaxel; Pelvic radiotherapy; prostate radiotherapy

UNICANCER - Recruiting 18 years to 75 years.
- A Randomized Phase III, Factorial Design, of Cabazitaxel and Pelvic Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse.
Cabazitaxel; Pelvic radiotherapy; prostate radiotherapy

Stage IA Pancreatic Adenocarcinoma, Stage IB Pancreatic Adenocarc Clinical Trial using nab-paclitaxel; gemcitabine

Fudan University - Recruiting 18 years to 75 years.
- A Phase II, Single-arm Study to Evaluate the Efficacy and Safety of the Combination of Nab-paclitaxel and Gemcitabine in Treating Patients With Pancreatic Cancer After Curative Resection.
nab-paclitaxel; gemcitabine

Pancreatic Cancer Metastatic Clinical Trial using Dasatinib; mFOLFOX6

University of Florida - Recruiting 18 years or older.
- Phase II Study of 5-Fluorouracil, Oxaliplatin Plus Dasatinib (FOLFOX-D) in First-line Metastatic Pancreatic Adenocarcinoma.
Dasatinib; mFOLFOX6

Pancreatic Ductal Adenocarcinoma Clinical Trial using The risk assessment questionnaire; Blood specimens; tumor tissue samples will be requested

Memorial Sloan-Kettering Cancer Center - Recruiting 21 years or older.
- A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma.
The risk assessment questionnaire; Blood specimens; tumor tissue samples will be requested

Gastric Cancer Clinical Trial using TS-1, oxaliplatin

Samsung Medical Center - Recruiting 20 years or older.
- .
TS-1, oxaliplatin

Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystade Clinical Trial using paclitaxel; carboplatin; bevacizumab; veliparib; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A PHASE I STUDY OF INTRAVENOUS CARBOPLATIN/PACLITAXEL OR INTRAVENOUS AND INTRAPERITONEAL PACLITAXEL/CISPLATIN IN COMBINATION WITH CONTINUOUS OR INTERMITTENT/ CTEP-SUPPLIED AGENT ABT-888 (NSC #737664) AND CTEP-SUPPLIED AGENT BEVACIZUMAB (NSC #704865) IN NEWLY DIAGNOSED PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN, FALLOPIAN TUBE OR PRIMARY PERITONEAL CANCER.
paclitaxel; carboplatin; bevacizumab; veliparib; laboratory biomarker analysis

Adenocarcinoma of the Colon Clinical Trial using Tinzaparin

Ottawa Hospital Research Institute - Recruiting 18 years or older.
- A Multicentre Randomized Controlled Trial of the Use of Extended Peri-Operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colon Cancer.
Tinzaparin

Rectal Cancer Clinical Trial using Questionnaire

M.D. Anderson Cancer Center - Recruiting N/A or older.
- A Pilot Study for Prospective Discovery of Possible Relationship Between Quality of Life, Treatment Modalities, and Patient Treatment/Outcome Expectations in Patients Undergoing Treatment for Locally Recurrent Rectal Adenocarcinoma.
Questionnaire

Gastric Cancer Clinical Trial using albumin-bounded paclitaxel; S-1

Chinese Academy of Medical Sciences - Recruiting 18 years or older.
- Pase 2 Study of Albumin-bounded Paclitaxel Plus S-1 as First-line Chemotherapy for Locally Advanced or Metastatic Gastric or Gastro-esophageal Adenocarcinoma.
albumin-bounded paclitaxel; S-1

Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian End Clinical Trial using paclitaxel poliglumex; clinical observation; paclitaxel

Gynecologic Oncology Group - Recruiting N/A or older.
- A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Single Agent Paclitaxel or CT-2103 (IND #70177), Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy.
paclitaxel poliglumex; clinical observation; paclitaxel

Prostate Cancer Clinical Trial using Proton Beam Therapy; Questionnaire

M.D. Anderson Cancer Center - Recruiting 18 years or older.
- Phase II Trial of Hypofractionated Proton Beam Therapy in Men With Localized Prostate Adenocarcinoma.
Proton Beam Therapy; Questionnaire

Gastric Adenocarcinoma Clinical Trial using Capecitabine, Oxaliplatin, Docetaxel

National Health Research Institutes, Taiwan - Recruiting 20 years or older.
- Using Genetic Polymorphisms of Drug Metabolism and Immunohistochemical Stain to Predict the Efficacy and Toxicity in Patients With Gastric Adenocarcinoma - A Phase II Study.
Capecitabine, Oxaliplatin, Docetaxel

Carcinomas (Including Squamous Cell and Adenocarcinoma), or Neopl Clinical Trial using blood draw

Stanford University - Recruiting 18 years or older.
- Development of Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy.
blood draw

Patients Must Have Histologically or Cytologically Confirmed Non- Clinical Trial using Paclitaxel, Carboplatin, Bevacizumab, and Metformin; Paclictaxl, Carboplatin, and Bevcizumab.

Sidney Kimmel Comprehensive Cancer Center - Recruiting 18 years or older.
- A Randomized Phase II Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Previously Untreated Advanced/Metastatic Pulmonary Adenocarcinoma.
Paclitaxel, Carboplatin, Bevacizumab, and Metformin; Paclictaxl, Carboplatin, and Bevcizumab.

Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian End Clinical Trial using bortezomib; carboplatin; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A PHASE I PHARMACOKINETIC STUDY OF INTRAPERITONEAL CTEP-SUPPLIED AGENT BORTEZOMIB (PS-341, NSC 681239, IND# 58443) AND CARBOPLATIN (NSC# 241240) IN PATIENTS WITH PERSISTENT OR RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER.
bortezomib; carboplatin; pharmacological study

Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Clinical Trial using cholecalciferol; genistein; placebo; laboratory biomarker analysis; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase IIA, Randomized Placebo-Controlled Trial of Single High Dose Cholecalciferol and Daily Genistein (G-2535) Versus Placebo in Men With Early Stage Prostate Cancer Undergoing Prostatectomy.
cholecalciferol; genistein; placebo; laboratory biomarker analysis; pharmacological study

Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcin Clinical Trial using Akt inhibitor MK2206; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase II, 2-stage, 2-arm PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer.
Akt inhibitor MK2206; laboratory biomarker analysis

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcin Clinical Trial using dinaciclib; Akt inhibitor MK2206; pharmacological study; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase I Trial of Dinaciclib (SCH727965) and MK-2206 in Metastatic Pancreatic Cancer With an Expansion Cohort in Advanced Pancreatic Cancer.
dinaciclib; Akt inhibitor MK2206; pharmacological study; laboratory biomarker analysis

Pancreatic Cancer Clinical Trial using GVAX pancreatic cancer vaccine; cyclophosphamide

Sidney Kimmel Comprehensive Cancer Center - Recruiting 18 years or older.
- A Randomized Three-arm Neoadjuvant and Adjuvant Feasibility and Toxicity Study of a GM-CSF Secreting Allogeneic Pancreatic Cancer Vaccine Administered Either Alone or in Combination With Either a Single Intravenous Dose or Daily Metronomic Oral Doses of Cyclophosphamide for the Treatment of Patients With Surgically Resected Adenocarcinoma of the Pancreas.
GVAX pancreatic cancer vaccine; cyclophosphamide

Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of Clinical Trial using panitumumab; irinotecan hydrochloride; fluorouracil; leucovorin calcium

Ohio State University Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Panitumumab in Combination With FOLFIRI After Progression on FOLFIRI Plus Bevacizumab in KRAS(Kirsten Rat Sarcoma) Wild-Type Metastatic Colorectal Cancer..
panitumumab; irinotecan hydrochloride; fluorouracil; leucovorin calcium

Prostate Cancer Clinical Trial using Cabazitaxel; Intensity Modulated Radiation Therapy (IMRT); Anti-Androgen Therapy: Bicalutamide; Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Thomas Jefferson University - Recruiting 18 years or older.
- Phase I Trial of Weekly Cabazitaxel With Concurrent Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy for the Treatment of Locally Advanced High Risk Adenocarcinoma of the Prostate.
Cabazitaxel; Intensity Modulated Radiation Therapy (IMRT); Anti-Androgen Therapy: Bicalutamide; Luteinizing Hormone-Releasing Hormone (LHRH) Agonist

Solid Tumors, Untreated Pancreatic Adenocarcinoma, Pancreatic Can Clinical Trial using PLX7486-TsOH; gemcitabine; nab-Paclitaxel

Plexxikon - Recruiting 18 years or older.
- A Phase 1 Study to Assess Safety, Pharmacokinetics, and Pharmacodynamics of PLX7486 as a Single Agent and in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced Solid Tumors.
PLX7486-TsOH; gemcitabine; nab-Paclitaxel

Breast Cancer, Pancreatic Cancer, Colorectal Cancer, Non-small-ce Clinical Trial using MORAb-066

Morphotek - Recruiting 18 years or older.
- A Phase I Study of the Safety, Tolerability, and PK of MORAb-066, a Humanized Monoclonal Antibody to Human TF, in Patients With Advanced or Metastatic Breast, Pancreatic, Colorectal, or NSCLC (Adenocarcinoma) Malignancies.
MORAb-066

Gastric Adenocarcinoma, or Esophageal Adenocarcinoma Clinical Trial using FLOT (5-fluorouracil, oxaliplatin, docetaxel)

McGill University - Recruiting 18 years or older.
- Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma.
FLOT (5-fluorouracil, oxaliplatin, docetaxel)

Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Clinical Trial using hypofractionated radiation therapy; laboratory biomarker analysis; image-guided radiation therapy; carboplatin; paclitaxel; stereotactic body radiation therapy

Jonsson Comprehensive Cancer Center - Recruiting 18 years or older.
- Image-Guided Hypofractionated Radiotherapy With Stereotactic Boost and Chemotherapy for Inoperable Stage II-III Non-Small Cell Lung Cancer.
hypofractionated radiation therapy; laboratory biomarker analysis; image-guided radiation therapy; carboplatin; paclitaxel; stereotactic body radiation therapy

Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of Clinical Trial using Akt inhibitor MK2206; laboratory biomarker analysis; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase 2 Study of MK-2206 in Previously Treated Metastatic Colorectal Cancer Patients Enriched for PTEN Loss and PIK3CA Mutation.
Akt inhibitor MK2206; laboratory biomarker analysis; pharmacological study

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcin Clinical Trial using alisertib; gemcitabine

University of California, Davis - Recruiting 18 years or older.
- Phase I Study of the Combination of MLN8237 and Gemcitabine in Advanced Solid Tumors With Emphasis on Pancreatic Cancer.
alisertib; gemcitabine

Pancreatic Adenocarcinoma, or Colorectal Cancer Clinical Trial

Oslo University Hospital - Recruiting N/A or older.
- The Process of Metastasis in Colorectal Cancer Tumour Biology and Prognostic Factors in Pancreatic Cancer.

Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma Clinical Trial using bevacizumab; oxaliplatin; leucovorin calcium; fluorouracil; laboratory biomarker analysis

USC/Norris Comprehensive Cancer Center - Recruiting 18 years or older.
- Phase II Trial Of Neoadjuvant Bevacizumab With Modified FOLFOX7 In Patients With Stage II And III Rectal Cancer.
bevacizumab; oxaliplatin; leucovorin calcium; fluorouracil; laboratory biomarker analysis

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage Clinical Trial using stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- High-Dose Stereotactic Body Radiation Therapy in Treating Patients With Low-, Intermediate-, or High-Risk Localized Prostate Cancer.
stereotactic body radiation therapy; quality-of-life assessment; laboratory biomarker analysis

Prostate Cancer Clinical Trial using hypofractionation

Sidney Kimmel Comprehensive Cancer Center - Recruiting 18 years or older.
- Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate.
hypofractionation

Stage IV Pancreatic Cancer Clinical Trial using nab-paclitaxel; Cisplatin; gemcitabine

Pancreatic Cancer Research Team - Recruiting 18 years or older.
- A Phase 1b/2 Pilot Trial of Nab-Paclitaxel Plus Cisplatin Plus Gemcitabine (Nabplagem) in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma (PDA).
nab-paclitaxel; Cisplatin; gemcitabine

Adenocarcinoma of the Ovary Clinical Trial using OVax: Autologous, DNP-Modified Ovarian Cancer Vaccine

AVAX Technologies - Recruiting 18 years or older.
- OVaxr: A Feasibility Study Using a DNP-Modified Autologous Ovarian Tumor Cell Vaccine as Therapy in Ovarian Cancer Patients After Relapse: A Feasibility Study Using a DNP-Modified Autologous Ovarian Tumor Cell Vaccine as Therapy in Ovarian Cancer Patients After Relapse.
OVax: Autologous, DNP-Modified Ovarian Cancer Vaccine

Adenocarcinoma of the Prostate Clinical Trial using Radiation Therapy; Androgen Deprivation Therapy (ADT)

Sidney Kimmel Comprehensive Cancer Center - Recruiting 18 years or older.
- Stereotactic Body Radiation Therapy and Short-Term Androgen Ablation for Intermediate-Risk, Localized, Adenocarcinoma of the Prostate.
Radiation Therapy; Androgen Deprivation Therapy (ADT)

Pancreatic Cancer Clinical Trial using Cyclophosphamide; PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1/GM-Neo vaccine; Stereotactic Body Radiation (SBRT); FOLFIRINOX

Sidney Kimmel Comprehensive Cancer Center - Recruiting 18 years to 76 years.
- Pilot Study Evaluating An Allogeneic GM-CSF-Transduced Pancreatic Tumor Cell Vaccine (GVAX) and Low Dose Cyclophosphamide Integrated With Fractionated Stereotactic Body Radiation Therapy (SBRT) and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas.
Cyclophosphamide; PANC 10.05 pcDNA-1/GM-Neo and PANC 6.03 pcDNA-1/GM-Neo vaccine; Stereotactic Body Radiation (SBRT); FOLFIRINOX

Gastric Cancer Clinical Trial using Oxaliplatin; Capecitabine

Harbin Medical University - Recruiting 65 years or older.
- A Randomized Single Center Phase II Study Comparing XELOX With Capecitabine Maintenance or XELOX Treatment in Elderly Metastatic Adenocarcinoma of Stomach.
Oxaliplatin; Capecitabine

Pancreatic Adenocarcinoma Clinical Trial using Gemcitabine

University of Tehran - Recruiting 18 years to 80 years.
- EUS-guided Intratumoral Gemcitabine Therapy in Locally Advanced Unresectable Pancreatic Cancer: A Phase 1 Study.
Gemcitabine

Colorectal Cancer Clinical Trial using capecitabine; 5-fluorouracil; Surgical Resection; Radiation therapy

UNC Lineberger Comprehensive Cancer Center - Recruiting 18 years or older.
- A Biologic Study of Global Gene Expression, NF-Kappa B and p53 in Adenocarcinoma of the Rectum..
capecitabine; 5-fluorouracil; Surgical Resection; Radiation therapy

Colorectal Cancer, or Metastasis Clinical Trial using Bevacizumab + blood samples

Centre Leon Berard - Recruiting 18 years or older.
- Exploration of New Biologic Factors' Predictive Value , Especially Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab.
Bevacizumab + blood samples

Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of Clinical Trial using PD-0332991; pharmacological study

Abramson Cancer Center of the University of Pennsylvania - Recruiting 18 years or older.
- Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer.
PD-0332991; pharmacological study

Rectal Cancer, Colon Cancer, Metastasis, or Adenocarcinoma Clinical Trial using Hydroxychloroquine; Oxaliplatin; Leucovorin; 5-fluorouracil; Bevacizumab

Abramson Cancer Center of the University of Pennsylvania - Recruiting 18 years or older.
- A Phase I/II Pharmacodynamic Study of Hydroxychloroquine in Combination With FOLFOX Plus Bevacizumab to Inhibit Autophagy in Colorectal Cancer.
Hydroxychloroquine; Oxaliplatin; Leucovorin; 5-fluorouracil; Bevacizumab

Gastric Adenocarcinoma, Gastroesophageal Adenocarcinoma, or Dista Clinical Trial using Cabazitaxel

Weill Medical College of Cornell University - Recruiting 18 years or older.
- An Open-Labeled, Multicenter Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma.
Cabazitaxel

Adenocarcinoma of Colon, Adenocarcinoma of Rectum, or Metastatic Clinical Trial using Arm A chemotherapy; arm B chemotherapy

Centro Nacional de Investigaciones Oncologicas CARLOS III - Recruiting 18 years to 76 years.
- Phase II Individualized Therapies Selection Study for Patients With Metastatic Colorectal Carcinoma According to the Genomic Expression Profile in Tumor Samples..
Arm A chemotherapy; arm B chemotherapy

Metastatic Pancreatic Adenocarcinoma Clinical Trial using Gemcitabine; Erlotinib; Oxaliplatin; Folinic Acid; Irinotecan; 5-FU

Ludwig-Maximilians - University of Munich - Recruiting 18 years to 75 years.
- Phase II Study to Evaluatate the Efficacy of Gemcitabine Plus Erlotinib for RASH-positive Patients With Metastatic Pancreatic Cancer and Friendly Risk Circumstances.
Gemcitabine; Erlotinib; Oxaliplatin; Folinic Acid; Irinotecan; 5-FU

Pancreatic Cancer Stage II, or Pancreatic Cancer Stage III Clinical Trial using Neoadjuvant gemcitabine, capecitabine, and docetaxel; Gemcitabine, capecitabine, docetaxel followed by radiotherapy

Columbia University - Recruiting 18 years or older.
- Phase II Study: Neoadjuvant Gemcitabine, Docetaxel and Capecitabine Followed by Neoadjuvant Radiation Therapy With Gemcitabine and Capecitabine in the Treatment of Stage II and III Pancreatic Adenocarcinoma.
Neoadjuvant gemcitabine, capecitabine, and docetaxel; Gemcitabine, capecitabine, docetaxel followed by radiotherapy

Pancreatic Cancer Clinical Trial using capecitabine; cisplatin; epirubicin; gemcitabine

IRCCS San Raffaele - Recruiting 18 years to 75 years.
- Randomized Phase II-III Trial of Peri- or Post-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma.
capecitabine; cisplatin; epirubicin; gemcitabine

Metastatic Adenocarcinoma of the Pancreas Clinical Trial using Gemcitabine, Intravenous and oral Ascorbic Acid (Vitamin C)

Eastern Regional Medical Center - Recruiting 18 years or older.
- Evaluation of the Safety and Efficacy of Standard Dose Gemcitabine Combined With High Dose Intravenous Vitamin C (HDIVC) Treatment for Patients With Metastatic Adenocarcinoma of the Pancreas..
Gemcitabine, Intravenous and oral Ascorbic Acid (Vitamin C)

Colorectal Cancer Clinical Trial using mechanical bowel preparation; enema

European Institute of Oncology - Recruiting 18 years to 80 years.
- Effect of Mechanical Bowel Preparation With Polyethylene Glycol Plus Bowel Enema (Glycerine 5%) vs Bowel Enema Alone in Patients Candidates to Colorectal Resection for Malignancy. Prospective, Randomized Clinical Trial.
mechanical bowel preparation; enema

Pancreatic Adenocarcinoma Clinical Trial using 5 Fluorouracil; Leucovorin; Irinotecan; Oxaliplatin

NorthShore University HealthSystem - Recruiting 18 years or older.
- A Pilot Study of Neoadjuvant and Adjuvant mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma.
5 Fluorouracil; Leucovorin; Irinotecan; Oxaliplatin

Adenocarcinoma of the Pancreas, or Metastatic Disease Clinical Trial using AUY922

University Health Network, Toronto - Recruiting 18 years or older.
- A Phase II Single Arm Study of AUY922 in Patients With Metastatic Pancreatic Adenocarcinoma Who Are Resistant to First Line Chemotherapy.
AUY922

Gastric Adenocarcinoma Clinical Trial using Oxaliplatin+S-1; Adjuvant Oxaliplatin/S-1(SOX)

Chinese PLA General Hospital - Recruiting 20 years to 75 years.
- Phase III, Randomized, Multicenter, Controlled Evaluation of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Advanced Gastric Cancer Patients.
Oxaliplatin+S-1; Adjuvant Oxaliplatin/S-1(SOX)

Gastrointestinal Neoplasm, or Gastric Adenocarcinoma Clinical Trial using Irinotecan-Capecitabine-Oxaliplatin

AHS Cancer Control Alberta - Recruiting 18 years or older.
- A Multicentre, Open-label Phase II Study of Irinotecan, Capecitabine(Xeloda), and Oxaliplatin (IXO) as First Line Treatment in Patients With Metastatic Gastric or Gastroesophageal (GEJ) Adenocarcinoma..
Irinotecan-Capecitabine-Oxaliplatin

Gastric Adenocarcinoma Clinical Trial using S-1 and Oxaliplatin

Sixth Affiliated Hospital, Sun Yat-sen University - Recruiting 18 years to 75 years.
- A Phase II Trial Evaluate a Modified SOX Regimen in First-Line Treatment of Unresectable Gastric Adenocarcinoma.
S-1 and Oxaliplatin

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous, or Carcinoma Clinical Trial using Docetaxel; Oxaliplatin

Korean South West Oncology Group - Recruiting 18 years or older.
- A Phase II Clinical Trial of Docetaxel, Oxaliplatin Combination Chemotherapy in Patients With Stage IIIB/IV Non-adenocarcinoma, Non-small Cell Lung Cancer (NSCLC) as Second-line Treatment.
Docetaxel; Oxaliplatin

Colorectal Cancer Clinical Trial using bevacizumab; capecitabine; fluorouracil; irinotecan hydrochloride; diagnostic laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years to 80 years.
- Phase II Study Evaluating the Association of Bevacizumab and Chemotherapy of the Type Modified FOLFIRI 3 in Patients With Metastatic Colorectal Adenocarcinoma.
bevacizumab; capecitabine; fluorouracil; irinotecan hydrochloride; diagnostic laboratory biomarker analysis

Adenocarcinoma of the Prostate Clinical Trial using Androgen suppression plus radiation therapy

McGill University - Recruiting 18 years to 85 years.
- A Phase II Study of Adjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma of the Prostate.
Androgen suppression plus radiation therapy

Esophageal Adenocarcinoma, or Gastric Adenocarcinoma Clinical Trial using panitumumab, epirubicin, oxaliplatin, xeloda

Massachusetts General Hospital - Recruiting 18 years or older.
- A Pilot Study of Perioperative Panitumumab in Combination With Epirubicin, Oxaliplatin and Xeloda in Patients With Resectable Gastroesophageal Adenocarcinoma.
panitumumab, epirubicin, oxaliplatin, xeloda

Esophageal Neoplasms, or Stomach Neoplasms Clinical Trial using Docetaxel, Oxaliplatin; Radiotherapy

Johannes Gutenberg University Mainz - Recruiting 18 years to 75 years.
- Prospective, Open, Multicentre Phase I/II Study to Evaluate the Safety and Efficacy of a Neoadjuvant Radiochemotherapy With Docetaxel and Oxalipaltin in Patients With Adenocarcinoma of the Gastric-Oesophageal Junction.
Docetaxel, Oxaliplatin; Radiotherapy

Colonic Diseases, or Adenocarcinoma Clinical Trial using leucovorin+5-FU

National Health Research Institutes, Taiwan - Recruiting 18 years to 70 years.
- Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer.
leucovorin+5-FU